×
About 275 results

ALLMedicine™ Acetylcholine Receptor Antibody Center

Research & Reviews  104 results

Positive acetylcholine receptor antibody in non-myasthenic patients.
https://doi.org/10.1002/mus.27500
Muscle & Nerve; Sun F, Tavella-Burka S et. al.

Jan 18th, 2022 - This study aims to investigate the frequency of acetylcholine receptor (AChR) binding antibody positivity via neuroautoimmunity panel testing, and describe its occurrence in a group of non-myasthenic disorders. This is a retrospective analysis of ...

The association between anti-acetylcholine receptor antibody level and clinical improve...
https://doi.org/10.1111/ene.15238
European Journal of Neurology; Marcuse F, Brandts L et. al.

Dec 31st, 2021 - Anti-acetylcholine receptor (AChR) antibodies (ab) in the serum are detected in most patients with generalized myasthenia gravis (MG) and used as a diagnostic tool. The aim of this study was to analyse a possible association between anti-AChR-ab s...

Roles of IL-35-producing T and B cells in anti-acetylcholine receptor antibody-positive...
https://doi.org/10.1016/j.jocn.2021.11.020
Journal of Clinical Neuroscience : Official Journal of Th... Li LM, Zhang LJ et. al.

Dec 21st, 2021 - Interleukin 35 (IL-35) plays an anti-inflammatory in numerous autoimmune diseases. However, the potential roles of IL-35-producing T and B cells and serum IL-35 levels in the pathogenesis of myasthenia gravis (MG) and its association with disease ...

Comparison of fixed cell-based assay to radioimmunoprecipitation assay for acetylcholin...
https://doi.org/10.1016/j.jns.2021.120084
Journal of the Neurological Sciences; Mirian A, Nicolle MW et. al.

Dec 16th, 2021 - To compare specificity and sensitivity of a commercially available fixed cell-based assay (F-CBA) to radioimmunoprecipitation assay (RIPA) for acetylcholine receptor antibody (anti-AChR) detection in myasthenia gravis (MG). In this retrospective d...

Effect of Buzhong Yiqi decoction on anti-acetylcholine receptor antibody and clinical s...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568406
Medicine Li J, Qi G et. al.

Dec 7th, 2021 - Ocular myasthenia gravis (MG) is the mainly widespread type of MG among juveniles. Buzhong Yiqi decoction (BZ) is a well-known traditional Chinese medicine prescription for treating MG. It has rarely been discussed whether the concentration of ant...

see more →

Clinicaltrials.gov  2 results

Study on Correlation Between Cytomegalovirus and Ocular Myasthenia Gravis
https://clinicaltrials.gov/ct2/show/NCT05091177

Oct 25th, 2021 - A total of 75 patients and 40 healthy volunteers are collected who are diagnosed with ocular myasthenia gravis in the First Affiliated Hospital of Jinan University from January 2019 to January 2022 . All subjects undergo eye examination and cytome...

Efficacy and Safety of Midodrine and Atomoxetine for Neurogenic OH
https://clinicaltrials.gov/ct2/show/NCT03350659

Apr 5th, 2019 - Visit 1. Enroll, baseline evaluation of the patients Questionnaire Evaluate orthostatic hypotension symptom: Orthostatic Hypotension Questionnaire (OHQ) Quality of life: Korean version of Short-form 36 Depressive symptom: Korean version of Beck De...

see more →

News  4 results

Potential First-in-Class, Targeted Therapy for Myasthenia Gravis
https://www.medscape.com/viewarticle/953330

Jun 17th, 2021 - Efgartigimod (argenx) is an effective and well-tolerated therapy for patients with generalized myasthenia gravis (gMG), new research suggests. Results from the phase 3, randomized, placebo-controlled ADAPT trial showed that reduction in disease bu...

Placebo response in negative rituximab BeatMG trial provides important lessons
https://www.mdedge.com/clinicalneurologynews/article/210310/neuromuscular-disorders/placebo-response-negative-rituximab/page/0/1?channel=39313

Oct 17th, 2019 - Suggestions from the data The post hoc subgroup analysis should be interpreted with caution, and the study does not provide firm conclusions, Dr. Nowak noted.

Cognitive Impairment and Autonomic Ganglionopathy
https://www.medscape.com/viewarticle/764741

Jun 5th, 2012 - Autoimmune Autonomic Ganglionopathy With Reversible Cognitive Impairment Gibbons CH, Centi J, Vernino S, Freeman R Arch Neurol. 2012;69:461-466 Study Summary Autoimmune autonomic ganglionopathy (AAG) is a rare form of severe autonomic failure link...

Myasthenia gravis therapy: Immunoadsorbent may eliminate need for plasma products
https://www.mdedge.com/ccjm/article/92699/myasthenia-gravis-therapy-immunoadsorbent-may-eliminate-need-plasma-products

Abstract This in vitro study assessed the effectiveness of a new immunoadsorbent (Asahi IM-TR 350) in removing anti-acetylcholine receptor antibody from plasma with minimal loss of albumin. Plasma procured from a myasthenia gravis patient undergoi.

see more →